Cookies on this website
We use cookies to ensure that we give you the best experience on our website. If you click 'Continue' we'll assume that you are happy to receive all cookies and you won't see this message again. Click 'Find out more' for information on how to change your cookie settings.

A new study, published in eLife, uses advanced tissue analysis technology to show how the incorporation of new proteins changes in bone and cartilage with age.

View through bone © Shutterstock

During ageing, cellular and physiological processes naturally decline and this is a particular problem in collagen-rich tissues such as the articular cartilage and bone, where tissue turnover is low and repair of the tissue is reduced with age. Reduced repair capacity increases the risk of common age-related diseases such as osteoarthritis (OA), non-union after bone fracture, and osteoporosis.

Protein studies have previously indicated levels of protein in a tissue at any given time, but are unable to provide information on how much is being newly synthesised and incorporated into the tissue. A new study, published in ELife,  uses a new methodology that gives researchers the ability to examine protein synthesis in situ, providing details of activity in the tissues under normal physiological conditions at different ages.

The tissues in the cartilage, bone and skin are made up of an extracellular matrix (ECM), which is a dynamic network composed of collagens and proteins, and collectively known as the matrisome.

The research team at the Kennedy Institute used an in vivo technique called pulsed SILAC labelling in healthy mice to show changes in the synthesis of proteins of the matrisome over three stages of life: during maximum skeletal growth, and at young, and older adulthood.

Metabolic labelling with stable isotopes in combination with quantitative proteomics were used to estimate the rates of incorporation of new proteins into cartilage, bone and skin. Plasma was used as a reference tissue comparator.

The study found that comparing young adult with older adult mice, new protein incorporation was reduced in all tissues and this was particularly marked in cartilage and bone. Changes were less apparent in skin, perhaps in line with what is known about its ability to self-renew throughout the healthy lifespan.

Tonia Vincent, Professor of Musculoskeletal Biology said: "Although new protein incorporation changes significantly in all tissues after skeletal maturity, it displays distinct temporal and molecular tissue signatures. As some of these changes affect pathways implicated in age-related disease, the study may be identifying tissue changes that predispose to subsequent osteoarthritis and osteoporosis."

Similar stories

A drug being trialled to treat cancer, could be the key to reducing gut inflammation

Published in Nature Communications, a new study reveals a new signalling pathway behind macrophage inflammatory activity

Large genetic study suggests shared biological processes cause irritable bowel syndrome and anxiety

An international study of more than 50,000 people with irritable bowel syndrome (IBS) has revealed that IBS symptoms may be caused by the same biological processes as conditions such as anxiety. The research highlights the close relationship between brain and gut health and paves the way for development of new treatments.

New therapeutic targets identified to treat inflammatory bowel disease

Millions of patients with ulcerative colitis or Crohn’s disease, collectively known as inflammatory bowel disease (IBD), are given fresh hope as a new study shows why some of them do not respond to current treatments.

Neutrophil molecular wiring revealed: transcriptional blueprint of short-lived cells

Researchers publish the first blueprint of transcriptional factors that control neutrophil-driven inflammation in Nature Immunology.

Exploring the link between joint injury and osteoarthritis

A new study published in The Lancet Rheumatology shows potential ways to predict how likely someone is to develop osteoarthritis after a knee injury.

Repurposed drug can induce remission of inflammatory arthritis

Researchers at the Kennedy Institute demonstrate that the drug decitabine can boost regulatory T cell responses.